Respiratory Syncytial Virus NP Antibody (B023): sc-58001

Respiratory Syncytial Virus NP Antibody (B023) is a mouse monoclonal IgG1 antibody that detects the Respiratory Syncytial Virus NP protein by immunofluorescence (IF). Anti-Respiratory Syncytial Virus NP antibody (B023) is available as a non-conjugated format. Respiratory Syncytial Virus NP protein plays a crucial role in the viral life cycle, primarily functioning as a nucleoprotein that encapsidates the viral RNA genome, protecting RNA from degradation and facilitating transcription and replication processes. Respiratory Syncytial Virus NP protein is essential for viral ribonucleoprotein complex formation, critical for viral mRNA synthesis and new virion assembly. Understanding Respiratory Syncytial Virus NP protein function is vital, as this protein aids in viral pathogenesis and serves as a potential target for therapeutic interventions and vaccine development. Respiratory Syncytial Virus causes significant respiratory illness in children, particularly those without vaccination or treatment, making Respiratory Syncytial Virus NP protein research imperative for public health.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

Respiratory Syncytial Virus NP Antibody (B023) References:

1. Respiratory syncytial virus: pervasive yet evasive.  |  Weir, E. and Fisman, DN. 2004. CMAJ. 170: 191. PMID: 14734430
2. Comparison of antibodies directed against human respiratory syncytial virus antigens present in two commercial preparations of human immunoglobulins with different neutralizing activities.  |  Sastre, P., et al. 2004. Vaccine. 23: 435-43. PMID: 15530691
3. Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children.  |  Belshe, RB., et al. 2004. J Infect Dis. 190: 2096-103. PMID: 15551207
4. The transmembrane domain of the respiratory syncytial virus F protein is an orientation-independent apical plasma membrane sorting sequence.  |  Brock, SC., et al. 2005. J Virol. 79: 12528-35. PMID: 16160180
5. Arrhythmias associated with respiratory syncytial virus infection.  |  Playfor, SD. and Khader, A. 2005. Paediatr Anaesth. 15: 1016-8. PMID: 16238569
6. Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain.  |  Cilla, G., et al. 2006. Epidemiol Infect. 134: 506-13. PMID: 16638164
7. Central role of the respiratory syncytial virus matrix protein in infection.  |  Ghildyal, R., et al. 2006. FEMS Microbiol Rev. 30: 692-705. PMID: 16911040
8. Isolation of respiratory syncytial virus from nasopharyngeal aspirates stored at 20 degrees C from one to fifteen months after collection.  |  Nunes, IF. and Moura, FE. 2006. Mem Inst Oswaldo Cruz. 101: 451-3. PMID: 16951818
9. Respiratory syncytial virus(RSV)-induced allergy may be controlled by IL-4 and CX3C fractalkine antagonists and CpG ODN as adjuvant: hypothesis and implications for treatment.  |  Becker, Y. 2006. Virus Genes. 33: 253-64. PMID: 16972041

Monoclonal antibodies for mammalian and non-mammalian protein targets represent essentially all targets covered by polyclonal antibodies. Over 8,300 of our antibodies are offered as ImmunoCruz^® conjugates which eliminates the need for a secondary antibody.

Santa Cruz Biotechnology antibodies have over 360,000 research citations. Anti-Respiratory Syncytial Virus NP Antibody (B023) has 1 citations in a variety of scientific publications.

Primary antibodies for mammalian target proteins are recommended for the detection of a range of mammalian species, primarily of mouse, rat and human species. Many mammalian antibodies are also ideal for veterinary research and reactive with ovine, porcine, caprine, feline, canine, bovine and equine protein targets. Santa Cruz Biotechnology primary monoclonal antibodies are suitable for laboratory research applications and are not intended for diagnostic or therapeutic use.

Respiratory Syncytial Virus NP Antibody (B023) Specifications

Alternate Product Name: Respiratory Syncytial Virus NP

Product Clone Name: B023

Classification: Primary Antibody

Clonality: Monoclonal Antibody

Antibody Isotype: IgG₁

Amino Acids:

Epitope Target: bovine origin and Respiratory Syncytial Virus strains A2, Long, Randall and 8/60

Epitope Species: RSV

Product Reactivity/Detection: Respiratory Syncytial Virus Nucleoprotein

Species Reactivity/Detection: Respiratory Syncytial Virus

Additional Mammalian Reactivity: N/A

Additional Non-Mammalian Reactivity: Respiratory Syncytial Virus

Applications: IF

Vialing Information: Each vial contains 100 µg IgG₁ in 1.0 ml of PBS with < 0.1% sodium azide and 0.1% gelatin

Research Citations: 1 citations in various scientific publications

Available Conjugates/Forms for Respiratory Syncytial Virus NP Antibody (B023): N/A